Supernus Pharmaceuticals, Inc.

We are a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Our extensive expertise in product development has been built over the past 25 years: initially as a standalone development organization, then as a U.S. subsidiary of Shire plc and, in late 2005, as Supernus Pharmaceuticals.

See Company Profile

Subcontent

Making a Better Tomorrow

Supernus’ vision is to be the leading specialty pharmaceutical company developing and commercializing new medicines in neurology and psychiatry. With over 25 years of product development experience, they continue to accomplish their mission by focusing on sales and marketing initiatives in the United States to attract new investors. 

Image
supernus d8 feature


 

Image
stocks-money-growth-chart-icon
 
Live stock ticker
Image
responsive devices icon
 
HTML flats for responsive design
Image
thumbs up
 
Higher retention rates for visitors
Image
analytics computer graph icon
 
Increased performance and flexibility in front-end design

Time to Adapt

When our team began this project, Supernus’ website was hindering their marketing efforts. It had a non-responsive design and was encumbering visitors with text-heavy pages. Because of our existing relationship, Supernus once again turned to Unleashed Technologies to update their website’s backend technology, provide a more intuitive experience for its visitors and create a responsive design. 

Image
supernus d8 tablet

Being a Leader in Innovation

Unleashed Technologies worked closely with Supernus to ensure that the new site offers an engaging interface that follows web best practices and powerfully communicates the vision of Supernus to its key audiences. 

In an effort to challenge traditional website design elements, our team created a sidebar main navigation menu on the right-hand side of the new website. In addition to leveraging an innovative design, Unleashed Technologies indexed the entire website by adding a site map to help both users and search engines locate content. 

Our team also upgraded the Drupal CMS to the most version of Drupal available. The new supernus.com now features: 

  • Drupal CMS advanced integration tools, content modeling, and configuration management 

  • An integrated investor relations site that provides real-time stock ticker information for visitors via a visually engaging presentation of key data 

  • HTML flats for a responsive design placing emphasis on usability 

  • A 200-percent reduction in load speed that created higher retention rates for visitors and quick caching updates 

  • Headless Drupal for splitting edit and display capabilities via Drupal 8 and Angular.js for flexible user interface design 

  • Angular.js framework that created a declarative user interface written in HTML programming language increasing performance and flexibility in front-end design 

Leveraging a Strategic Collaboration

When the new website launched in June 2016, Supernus received feedback that the site was more intuitive, accessible, and responsive than ever before. With a prominent navigation to the most desired sections and proper text length for easy scanning and readability, visitors can quickly find what they want within each page. 

New workflow applications have also helped heighten Supernus’ marketing efforts in the United States. They have increased visibility in their marketplace and new investor relations, ultimately driving growth and profitability. 


 

Awards

Image
w3 awards
2016 Silver Winner - W3 Awards Website Features: User Experience
Image
communicator award
2017 Communicator Award
 

I appreciate Unleashed Technologies' ability to problem-solve in a unique way. They have no boundaries in terms of ability. If a client needs a certain piece of functionality or flow, Unleashed Technologies will put time and effort into learning what it will take to complete that task.

Image
Supernus Logo

Megan Greenwell

Manager, Database Administrator,
Supernus Pharmaceuticals, Inc.